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Diabetes mellitus (DM) is a major cause of morbidity 
and mortality globally. In 2010 an estimated 285 
million adults had DM. This was projected to rise to 
439 million adults by 2030; however, the most recent 
International Diabetes Federation estimates are that in 
2014, 387 million people already had DM, and by 2035 this will rise to 
592 million. The prevalence of DM continues to increase, with the largest 
increase seen in low- and middle-income countries; in South Africa (SA) 
the prevalence is also rising.[1-5] This increase is mainly due to the growth 
and ageing of the population, as well as rising rates of urbanisation with 
associated increased levels of obesity, physical inactivity and unhealthy 
diet.[6-8] This escalating number of people with DM will impact on disease 
management systems. DM accounted for 4.3% of all deaths in SA in 2000, 
placing it as the seventh most common cause of death in this country.[6]
The complications of DM are not only common but devastating, 
and include lower extremity amputations (LEAs), blindness and renal 
failure, with DM being the most common cause for non-trauma-
related LEAs. There is a wide range in the proportion of LEAs due 
to DM, with studies showing that up to 90% of LEAs worldwide are 
associated with DM and up to 70% of patients who undergo an LEA 
die within 5 years of the operation.[6,9,10]
There are some African data on diabetes-related LEAs, primarily 
from small tertiary hospital studies. In each, diabetic foot com-
plications were the major indication for non-traumatic LEAs.[11-13] 
There are, however, few published data available for SA, and this 
study attempts to address this deficit, providing a baseline from 
which further monitoring and planning can be done.
The aim of this study was to examine the contribution of DM 
to the burden of LEAs in four public sector hospitals in Cape 
Town, SA, during 2009 and 2010. The objectives were to determine 
the demographic characteristics of patients undergoing LEAs, the 
proportion of these amputations due to DM, the comorbidities, risk 
factors, causes and complications associated with these LEAs, and the 
number and sites of these LEAs.
Methods
The study was a retrospective analysis of all LEAs performed in four 
Cape Town public sector hospitals: Groote Schuur Hospital, a tertiary 
level hospital, and its associated secondary level hospitals, Somerset, 
Victoria and G F Jooste Hospitals, from 1 January 2009 to 31 December 
2010. These are the public sector hospitals that perform LEAs in the 
western portion of the Cape Town metropole. Cape Town is situated in 
the Western Cape Province of SA and has a heterogeneous population 
of approximately 3.5 million people. Like the rest of SA, disease 
management is split between the public and private sectors, with 80% 
of the population being dependent on the public sector.[14,15]
All cases of LEAs, defined as the surgical removal of part of 
the lower limb by transection of the leg, foot or digit, necessarily 
including the removal of bone,[16] were identified from the theatre 
registers of these four hospitals for 2009 and 2010. All cases 
including the terms above-knee amputation (AKA), through-knee 
amputation (TKA), below-knee amputation (BKA), supramalleolar 
amputation (SMA), forefoot/transmetatarsal amputation (TMA) and 
digit amputation (DA) were included as an LEA in this study.
The identified patients’ records were requested from the 
corresponding hospitals’ records departments, and information 
was extracted using a structured data capture form. The data 
collected included number and length of admissions, demographic 
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details, diabetic status, type and treatment, 
associated comorbidities, risk factors, cause, 
amputation details and complications.
Trauma-related LEAs were excluded. 
Of the non-trauma-related LEAs, patients 
whose diabetic status was unknown were also 
ex cluded.
Descriptive analysis included percentages 
for categorical data, means, medians, stan-
dard deviations and ranges for numerical 
data where appropriate. Tests of significance 
included the χ2, Fisher’s exact and Wilcoxon 
tests. Statistical significance of p<0.05 was 
used.
The study was approved by the University 
of Cape Town Ethics Research Committee, 
HREC Ref: 365/2011. Permission to access 
patient records from the various hospitals 
was received.
Results
As seen in Fig. 1, records for 941 patients 
were found from the 1 134 patients identified 
as having an LEA from theatre records, a 
recovery rate of 82.9%. After exclusion of 
39 patients who had a traumatic LEA and a 
further 35 with unknown DM status, a total 
of 867 patients with 1 280 LEAs remained, 
593 DM patients with 925 LEAs and 274 
non-DM patients with 355 LEAs; 72.3% 
(95% confidence interval (CI) 69.8 - 74.7) 
and 27.7% (95% CI 25.4 - 30.3) of the LEAs 
were therefore in DM and non-DM patients, 
respectively. Of the total number of patients, 
68.4% (95% CI 65.2 - 71.4) had DM.
The mean age (standard deviation (SD)) of 
all included patients was 62.2 (12.74) years. 
There was no significant difference in the 
mean age of men and women within and 
between the DM and non-DM groups. 
There were similar proportions of men and 
women in the DM group (50.1% and 49.9%, 
respectively), but twice as many men as 
women in the non-DM group (66.8% v. 
33.2%, p<0.001). (The patient records no 
longer include a population classification 
code, so this information is not reported.)
Type 2 DM accounted for the majority 
of the patients in the DM group (n=551, 
92.9%); 7 patients (1.2%) had type 1 DM, 
while the type of diabetes was unknown in 
35 (5.9%). Regarding therapy, 299 (50.4%) 
were on oral therapy, 104 (17.5%) were on 
insulin, 128 (21.6%) were on a combination 
of oral and insulin therapy, 3 (0.5%) were on 
no therapy, 7 (1.2%) were on diet alone and 
therapy in 52 (8.8%) was unknown.
Table 1 summarises the comorbidities, risk 
factors, causes and complications asso ciated 
with an LEA in the DM and non-DM groups.
Comorbidities. Hypertension, ischaemic 
heart disease (IHD) and renal impairment 
were significantly more common in the DM 
group than in the non-DM group (p<0.001). 
Conversely, associated alcohol use, asthma/
chronic obstructive pulmonary disease (COPD) 
and HIV infection, were more common in 
the non-DM than the DM group (p<0.001), 
but associated cerebral vascular accidents 
(CVAs)/transient ischaemic attacks (TIAs) and 
congestive cardiac failure frequencies did not 
differ in the DM and non-DM groups.
Associated risk factors. Smoking was 
the only associated risk factor that was 
significantly different between the two 
groups (43.5% in the DM group and in 
69.7% in the non-DM group; p<0.001).
Causes of the LEAs. Infection was 
the major cause of LEAs in both groups, 
albeit significantly higher in the DM group 
(p<0.001). Ischaemia accounted for a signi-
ficantly greater proportion of LEAs in the 
non-DM group (p<0.001), whereas an ulcer 
was responsible for a significantly greater 
proportion of LEAs in the DM group 
(p=0.001). Less common causes, including 
burns (p<0.05), were more common in the 
DM group, while malignancy (p<0.01), 
limb deformity (p<0.05), neurological 
disorder (p<0.01) and HIV vasculopathy 
(p<0.01) were more common in the non-
DM group.
Complications associated with the LEAs. 
There were significant differences for the 
main complications between the two groups, 
with a further LEA, sepsis and debridement 
being more common in the DM group than 
the non-DM group (p<0.05). There was no 
significant difference for the other main 
complications of in-hospital death, blood 
transfusion, and intensive care unit (ICU) 
admission, or regarding other complications 
of deep-vein thrombosis (DVT), upper 
gastrointestinal tract (GIT) bleed and 
pneumonia between the DM and non-DM 
groups, although these numbers were very 
small.
The median duration of hospital admission 
was 9 days, with an interquartile range of 7 
days for both groups, and a range of 1 - 45 
Identied from
theatre registers
Recovery rate: 82.9%
Excluded from study
Excluded from study
Patient records found
Traumatic amputations
Non-trauma-related LEAs
Diabetes status unknown
Diabetes status known
1 517 LEAs in 1 134 patients
1 374 LEAs in 941 patients
44 LEAs in 39 patients
1 330 LEAs in 902 patients
50 LEAs in 35 patients
1 280 LEAs in 867 patients
925 LEAs in
593 diabetes patients
(72.3% of all LEAs)
355 LEAs in
274 non-diabetes patients
(27.7% of all LEAs)
Fig. 1. Flow diagram for inclusion and exclusion of patients in the study.
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days for the DM patients and 1 - 79 days for 
the non-DM patients. The 867 patients in the 
study were admitted 988 times; there were 
688 admissions in the 593 DM patients and 
300 admissions in the 274 non-DM patients. 
Multiple admissions were more common in 
the DM patients (14.3%) compared with the 
non-DM patients (7.7%) (p<0.005).
The DM group had a greater proportion 
of current multiple LEAs than the non-
DM group (42% v. 23%, p<0.001), while 
20.4% in the DM group and 17.2% in the 
non-DM group had an LEA prior to the 
commencement of the study.
As seen in Fig. 2, the proportions of 
multi ple toectomies and TMAs did not 
differ significantly between the two groups. 
However, the proportions of single toec-
tomies (p=0.002), SMAs (p<0.0001), and 
BKAs (p<0.0001), were higher in the DM 
patients, while TKAs (p<0.0001) and AKAs 
(p<0.0001) were higher in the non-DM 
group.
Discussion
DM accounted for the vast majority of non-
traumatic LEAs performed in 2009 and 2010 
in four public sector hospitals in Cape Town. 
On average six (number rounded up from 
5.7) DM patients had nine (number rounded 
up from 8.9) LEAs per week over the 2-year 
period.
These data highlight the considerable 
burden that diabetes-related LEAs impose 
on local health services. This is in keeping 
with numerous studies conducted elsewhere 
that have stated that LEAs represent a 
considerable cost for such services, not 
only for the admission and amputation, 
but also for the additional components 
of rehabilitation, home care and social 
services.[6,9,17,18] The human cost is also 
considerable for the patients, their families 
and society. The best way to decrease these 
costs is to decrease the number of foot 
complications, including LEAs.
Table 1. Comparison of comorbidities, risk factors, causes and complications between 
DM and non-DM patients having a lower extremity amputation
DM group
 n (%)
Non-DM group
 n (%) p-value
Comorbidities
Hypertension 493 (83.1) 148 (54.0) <0.001
CVA/TIA 76 (12.8) 40 (14.6) 0.4735
Ischaemic heart disease 103 (17.4) 29 (10.6) 0.0097
Alcohol 28 (4.7) 41 (15.0) <0.001
Asthma/COPD 24 (4.1) 27 (9.9) <0.001
Congestive cardiac failure 33 (5.6) 8 (2.9) 0.088
Renal impairment 28 (4.7) 3 (1.1) 0.0074
HIV 2 (0.3) 23 (8.4) <0.001
Risk factors 
Hypercholesterolaemia 75 (12.7) 27 (9.9) 0.2359
Smoking 258 (43.5) 191 (69.7) <0.001
Peripheral vascular disease 138 (23.3) 76 (27.7) 0.1563
Peripheral neuropathy 13 (2.2) 3 (1.1) 0.2653
Causes
Ulcer 150 (25.3) 42 (15.3) 0.001
Infection 508 (85.7) 174 (63.5) <0.001
Ischaemia 138 (23.3) 135 (49.3) <0.001
Complications
In-hospital death 34 (5.7) 17 (6.2) 0.7841
Further amputation 250 (42.2) 63 (23.0) <0.001
Blood transfusion 65 (11.0) 24 (8.8) 0.3206
Diabetic ketoacidosis 12 (2.0)
ICU admission 10 (1.7) 5 (1.8) 0.5399
Sepsis/debridement 52 (8.8) 13 (4.7) 0.0364
Other complications* total 9 (1.5) 4 (1.5) 0.9781
*Other complications included vascular event, DVT, upper GIT bleed and pneumonia.
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Fig. 2. Distribution (%) of current LEAs by site in the DM and non-DM patients. (*Indicates significant differences (p<0.002) between DM and non-DM groups.)
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This study found that the associated co morbidities of hypertension, 
IHD and renal impairment were more common in the DM patients. 
This is similar to other studies and is thought to be due in part to 
the increasing westernisation of lifestyles.[3,19,20] The associated renal 
impairment probably reflects complications of DM due to poor 
glycaemic control.
Smoking was the only associated risk factor found to be different, 
being more prevalent in non-DM patients. This was also reflected 
in the fact that associated asthma/COPD was more prevalent in 
the non-DM group. Yet a large proportion of DM patients (43%) 
smoked, which is of concern, as smoking is known to increase the 
risk of LEAs in people with DM.[19] Associated peripheral vascular 
disease (PVD) was similar between the DM and non-DM groups, 
with about 25% of patients noted to have PVD as a risk factor, 
which is similar to a previous study.[21] This study found only a small 
number of patients with associated peripheral neuropathy in the DM 
group, yet peripheral neuropathy is known to be a substantial cause 
of foot complications including LEAs.[8,22] The number of patients 
with associated peripheral neuropathy is probably artificially low, 
reflecting under-reporting in the patient records.
A preceding ulcer and infection were the more common causes for 
LEAs in the DM patients, which is in keeping with what previous studies 
have shown.[3,9,17,19,23] Ischaemia was the most common cause for LEAs in 
the non-DM patients, perhaps reflecting the higher rate of smoking in 
this group. Burns causing LEAs were more common in the DM group 
and can probably be attributed to associated peripheral neuropathy. 
Under-reporting of peripheral neuropathy probably reflects failure on 
the part of healthcare workers to screen for this complication. They are 
therefore not educating patients on the danger of infections, burns, etc.
Post-LEA sepsis and debridements were found to be more 
common in the DM patients. This was expected, as sepsis was often 
the cause for the LEA in this group. Nearly 20% of LEAs in DM 
patients were SMAs. This indicates that sepsis was a major cause, 
as this operation is usually a sepsis control procedure, the definitive 
procedure being a BKA or AKA. It is also notable that the percentage 
of AKAs in the non-DM group was double that in the DM group. 
This may be because DM patients have more LEAs due to an ulcer 
or infection, requiring a more distal amputation, whereas non-
DM patients have more LEAs due to ischaemia, requiring a more 
proximal amputation. The greater proportion of current, multiple 
LEAs in the DM group compared with the non-DM group reflects 
the fact that ‘creeping’ LEAs, i.e. multiple LEAs that start distally and 
progress proximally, are more prevalent in the DM group.
The strengths of this study are the large numbers of patients 
identified with a good recovery rate, as well as similar methodology 
employed as in other global studies.[24] However, it has a number 
of limitations. Its retrospective nature allowed only for information 
recorded in the patient folders to be evaluated. Accurate data for 
comorbidities, risk factors, causes and complications associated with 
a LEA would require a prospective study. The records often revealed 
limited information on other factors such as the level of glycaemic 
control, duration of DM and obesity. The study was undertaken 
only in the public sector, thus underestimating the true burden 
of diabetes-related LEAs. Because of the lack of accurate data on 
DM incidence and population size in the study area, it is difficult 
to extrapolate the number of LEAs identified in this study to the 
prevalence of diabetes-related LEAs.
It is well known that the majority of foot complications, including 
LEAs, are preventable with adequate patient education, screening, 
treatment and follow-up.[3,16,23,25,26] In this regard we have previously 
demonstrated that a third of patients attending primary care clinics in 
Cape Town had ‘at-risk feet’ although this had often been unrecorded 
in the clinic notes.[27] A number of reasons may account for suboptimal 
foot care: high patient numbers and decreased consultation times 
leading to infrequent foot examinations, limited opportunities for 
patient education and therefore non-adherence, as well as inadequate 
overall treatment at a primary healthcare level.[6,19,28] While preventive 
diabetes foot care is not the sole preserve of the doctor or a podiatrist, 
it is important to note that there is a lack of podiatrists to adequately 
prevent and treat these complications. Nurses, health promoters 
and community health workers can all contribute to a diabetes foot 
programme, but would need to receive appropriate training to enable 
patients to be active participants in their own care, to screen for at-risk 
feet and to refer appropriately for further management.
Conclusions
This study highlights the enormous burden of LEAs in the public 
sector. There is clearly an urgent need to develop and implement 
foot care programmes to reduce the personal, societal and disease 
management costs associated with LEAs. This study provides a 
baseline against which the effectiveness of interventions can be 
measured in the future.
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